Celyad Oncology SA (EBR:CYAD)
Belgium
· Delayed Price · Currency is EUR 0.185
0.00 (0.00%)
Dec 5, 2025, 5:28 PM CET
Celyad Oncology Revenue
Celyad Oncology had revenue of 14.00K EUR in the half year ending June 30, 2025, a decrease of -68.18%. This brings the company's revenue in the last twelve months to 186.00K, up 158.33% year-over-year. In the year 2024, Celyad Oncology had annual revenue of 186.00K with 82.35% growth.
Revenue
186.00K
Revenue Growth
+158.33%
P/S Ratio
44.52
Revenue / Employee
10.33K
Employees
19
Market Cap
8.28M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 3.14B |
| UCB SA | 6.85B |
| Financière de Tubize | 13.26K |
| Fagron NV | 918.75M |
| Ion Beam Applications | 585.76M |
| Onward Medical | 2.72M |
| Hyloris Pharmaceuticals | 8.46M |
| Nyxoah | 5.64M |